As of 2025-12-25, the Relative Valuation of Biosynex SA (ALBIO.PA) is (75.51) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.59 EUR, the upside of Biosynex SA based on Relative Valuation is -12811.3%.
The range of the Relative Valuation is (67.05) - (80.64) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 20.6x | 17.2x |
| Forward P/E multiples | 11.0x - 16.5x | 13.8x |
| Fair Price | (67.05) - (80.64) | (75.51) |
| Upside | -11388.0% - -13675.2% | -12811.3% |
| Date | P/E |
| 2025-12-24 | -0.12 |
| 2025-12-23 | -0.12 |
| 2025-12-22 | -0.12 |
| 2025-12-19 | -0.12 |
| 2025-12-18 | -0.12 |
| 2025-12-17 | -0.12 |
| 2025-12-16 | -0.13 |
| 2025-12-15 | -0.12 |
| 2025-12-12 | -0.10 |
| 2025-12-11 | -0.10 |
| 2025-12-10 | -0.10 |
| 2025-12-09 | -0.10 |
| 2025-12-08 | -0.10 |
| 2025-12-05 | -0.10 |
| 2025-12-04 | -0.10 |
| 2025-12-03 | -0.10 |
| 2025-12-02 | -0.10 |
| 2025-12-01 | -0.10 |
| 2025-11-28 | -0.10 |
| 2025-11-27 | -0.10 |
| 2025-11-26 | -0.10 |
| 2025-11-25 | -0.10 |
| 2025-11-24 | -0.10 |
| 2025-11-21 | -0.11 |
| 2025-11-20 | -0.11 |
| 2025-11-19 | -0.11 |
| 2025-11-18 | -0.11 |
| 2025-11-17 | -0.10 |
| 2025-11-14 | -0.11 |
| 2025-11-13 | -0.11 |
| 2025-11-12 | -0.11 |
| 2025-11-11 | -0.11 |
| 2025-11-10 | -0.11 |
| 2025-11-07 | -0.11 |
| 2025-11-06 | -0.10 |
| 2025-11-05 | -0.11 |
| 2025-11-04 | -0.12 |
| 2025-11-03 | -0.12 |
| 2025-10-31 | -0.13 |
| 2025-10-30 | -0.13 |
| 2025-10-29 | -0.13 |
| 2025-10-28 | -0.13 |
| 2025-10-27 | -0.13 |
| 2025-10-24 | -0.13 |
| 2025-10-23 | -0.14 |
| 2025-10-22 | -0.14 |
| 2025-10-21 | -0.14 |
| 2025-10-20 | -0.14 |
| 2025-10-17 | -0.14 |
| 2025-10-16 | -0.14 |